Master's Programme Pharmaceutical Sciences -
Drug Development and Regulatory Affairs

Joint Study Programme of the University of Innsbruck and the Medical University of Innsbruck

Faculty Faculty of Chemistry and Pharmacy
Duration / ECTS-Credits 4 semesters / 120 ECTS-Credits
Academic Degree
Master of Science (MSc)
Qualification Level
Master (Second Cycle)
ISCED-11: Level 7, EQF/NQF: Level 7
ISCED-F 0916 Pharmacy
Mode of Study
Study Code UC 066 607
Curriculum Information on the Curriculum (2022W)*
Language of Instruction English
Admission Requirements Relevant bachelor's degree or equivalent and Language Certificates
Application » Information about the Admission Procedure

* Information on the Curriculum (2022W)

The complete version of the curriculum reflects the currently valid version of the curriculum. It is for informational purposes only and is not legally binding. The legally binding version of the curriculum, including any amendments, may be found in the University of Innsbruck Bulletins.

In order to determine which version of the curriculum is applicable in your case, see the Catalogue of Studies,
  available at:
  Section: Current Curriculum version.

University of Innsbruck Bulletins » (Click to open all University of Innsbruck Bulletins)


Relevant bachelor's degrees at the University of Innsbruck:

Relevant bachelor's degree at the Medical University of Innsbruck:


 Proof of general university entrance qualification: 

The general university entrance qualification for admission to a master's programme must be proven by the completion of a subject-related bachelor's programme, another subject-related programme of at least the same higher education level at a recognised domestic or foreign post-secondary educational institution, or a program defined in the curriculum of the master's programme. To compensate for significant differences in subject matter, supplementary examinations (maximum 30 ECTS credits) may be prescribed, which must be taken by the end of the second semester of the master's programme. The rectorate may determine which of these supplementary examinations are prerequisites for taking examinations provided for in the curriculum of the master's programme.

In the course of the proof of the general university entrance qualification, the completion of the following core areas within the framework of the completed bachelor's degree programme shall be examined in any case:

in progress

Recommended Course Sequence

The exemplary course sequence given below is recommended for full-time students beginning their study programme in the winter semester. The table shows one possible course sequence for the bachelor's programme and is not compulsory. Delays resulting from repeated examinations are not taken into account.

The standard duration of the study programme is 4 semesters or 120 ECTS-Credits, whereby according to the Universities Act of 2002, a workload of 1,500 (real) hours per academic year must be fulfilled, corresponding to 60 ECTS-Credits (one ECTS-Credit is equivalent to a workload of 25 hours).

First semester »

7.5 ECTS-Credits: Introduction
15.0 ECTS-Credits: Preclinical Research and Development
7.5 ECTS-Credits: Quality Aspects of Investigational Medicinal Products (IMP)

Second semester »

7.5 ECTS-Credits: Clinical Development of Medicinal Products
7.5 ECTS-Credits: Biostatistics and Data Management
7.5 ECTS-Credits: Conducting Clinical Trials

7.5 ECTS-Credits: Matters of Medicines Regulation and Market Approval

Third semester »

15.0 ECTS-Credits: Application for Clinical Trial and Approval
15.0 ECTS-Credits: Elective Modul: „Practice in Industry“ or „Specialisation in Medicinal Product Development and Regulating Environment“

Fourth semester »

2.5 ECTS-Credits: Preparation of the Master's Thesis
25.0 ECTS-Credits: Master's Thesis
2.5 ECTS-Credits: Master's Thesis Defence

Graphic chart »

in process

Qualification Profile and Skills

Applicants should have a basic knowledge in scientific field relevant to understand the mechanisms of drug action and how this could help to treat human disease. They should be interested to learn all methodologies and required regulatory steps to bring a clinical candidate drug into the clinics and finally use them safely in patients.

Expected Learning Outcomes

The objectives of this joint master's programme are to train experts who understand the processes required for the development of new medicinal products in their entirety and can apply and successfully implement them in their future professional environment. Graduates receive a professional and scientifically sound education in the field of drug development and the regulations required for this. This includes relevant knowledge of molecular disease processes that can be influenced by medicinal products and the molecular structures that can be used as therapeutics. Graduates have detailed knowledge of the strategies, methods and the theoretical and practical regulatory knowledge required for the preclinical and clinical development and testing of medicinal products for successful market authorisation in Europe. As a result, they are able to independently and successfully plan complex projects within the framework of modern drug development, organise them accordingly, carry them out and accompany them until final market approval. They have the opportunity to further specialise in the field of medicinal products within the framework of application-oriented projects.

Future Prospects: Occupational Profiles and Career Opportunities

The master’s programme qualifies students for later successful employment in particular with pharmaceutical companies, drug authorities, clinical testing organisations and for further studies in national and international doctoral programmes.

Postgraduate and further Studies at the University of Innsbruck

Information about examination regulations, assessment and grading

Examination regulations

The examination regulation is an integral part of the curriculum, detailed information can be found under the paragraph examination regulations.

Description of the applied grading system (including the grade distribution table) »

The grade distribution table is a statistical representation of the distribution of all successfully completed examinations in a given programme of study or subject (based on all registered students for the programme or subject). The grade distribution table is updated in regular intervals.

Austrian grading
Outstanding performance

= 100%


Generally good, but with some errors

Generally sound work with a number of substantial errors

Performance meets the minimum criteria

Substantial improvement necessary; requirement of further work

in process

Overall classification of the qualification

Not applicable
Explanation: An overall classification (mit Auszeichnung bestanden/pass with distinction, bestanden/pass, nicht bestanden/fail) – is awarded only for examinations that conclude a programme of study and consist of more than one subject (an examination of this type is not specified in the curriculum of this programme of study). 

Information about the Programme

Forms (in German only)

Contact and Information

Examination Office
Standort Innrain 52d Piktogramm barrierefreier Zugang

Associate Dean of Studies at the University of Innsbruck
Ao. Univ.-Prof. Mag. Dr. Alexandra Koschak

Information for students with disabilities 

Nach oben scrollen